These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11997563)

  • 1. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
    Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA
    Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
    Oudkerk M; Torres CG; Song B; König M; Grimm J; Fernandez-Cuadrado J; Op de Beeck B; Marquardt M; van Dijk P; de Groot JC
    Radiology; 2002 May; 223(2):517-24. PubMed ID: 11997562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
    Youk JH; Lee JM; Kim CS
    AJR Am J Roentgenol; 2004 Oct; 183(4):1049-54. PubMed ID: 15385303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
    Yeh BM; Breiman RS; Taouli B; Qayyum A; Roberts JP; Coakley FV
    Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
    Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
    Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis.
    Sheridan MB; Ward J; Guthrie JA; Spencer JA; Craven CM; Wilson D; Guillou PJ; Robinson PJ
    AJR Am J Roentgenol; 1999 Sep; 173(3):583-90. PubMed ID: 10470884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
    Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
    Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
    Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
    Kim SK; Kim SH; Lee WJ; Kim H; Seo JW; Choi D; Lim HK; Lee SJ; Lim JH
    AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.